Clinical Research Directory
Browse clinical research sites, groups, and studies.
Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery
Sponsor: Eye & ENT Hospital of Fudan University
Summary
Phase II, single-arm, prospective clinical study of Toripalimab(a PD-1 antibody) combined with radiotherapy and chemotherapy in the treatment of sinonasal malignant mucosal melanoma after endoscopic surgery.
Official title: Phase II, Single-arm, Prospective Clinical Study of Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of Sinonasal Malignant Mucosal Melanoma(SNMM) After Endoscopic Surgery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2021-05-01
Completion Date
2026-05-01
Last Updated
2024-03-05
Healthy Volunteers
No
Conditions
Interventions
endoscopic surgery
endoscopic surgery followed by multimodality treatment including radiotherapy,Toripalimab,and/or chemotherapy
Locations (1)
Eye& ENT Hospital, Fudan University
Shanghai, Shanghai Municipality, China